Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Terminated 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Melanoma 4Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma 2Waldenstrom Macroglobulinemia 1Solid Tumor 1Skin Neoplasms 1Sezary Syndrome 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1

Interventions

Cyclophosphamide 5nilotinib 4Cytarabine 4fludarabine 3Methotrexate 3Imatinib Mesylate 3Dasatinib 3Busulfan 3fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cyclosporine 2AP 1903 reagent 2sargramostim 1ruxolitinib 1merphos 1amsonic acid 1Whole-Body Irradiation 1Vincristine 1Valproic Acid 1Thiotepa 1Tacrolimus 1Sirolimus 1Saline Solution 1Rituximab 1Prednisone 1Ondansetron 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × sargramostim × Clear all
NCT00446173 2015-08-25

Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia

M.D. Anderson Cancer Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡